Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.28 USD | +1.33% | -8.06% | -25.25% |
06-25 | Needham Lowers Price Target on G1 Therapeutics to $6 From $12, Maintains Buy Rating | MT |
06-25 | HC Wainwright Lowers G1 Therapeutics Price Target to $3 From $9, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.25% | 119M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- GTHX Stock
- News G1 Therapeutics, Inc.
- Transcript : G1 Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-12-2022 01